Precautions and contraindications while taking Erlotinib/Tarceva

As a representative of EGFR-targeted therapy, Erlotinib (Erlotinib) requires attention to a series of factors that affect absorption, metabolism, and toxicity management during its administration. In order to ensure that patients have a more stable and safer treatment experience, many overseas clinical medication guidelines have detailed its contraindications. Patients can master these precautions during treatment to help them adhere to the medication for a long time and maintain a better quality of life.

The first caution is to avoid co-use with strong acid-suppressing drugs. Erlotinib needs to be absorbed under acidic conditions, so taking proton pump inhibitors, H2 blockers or large amounts of antacids at the same time may significantly reduce the effective exposure of the drug and reduce the anti-tumor effect. If the patient really needs to use gastric medicine, the doctor should arrange a separate time or adjust the treatment method according to the specific situation.

The second important step is skin management. Since EGFR is also expressed in skin cells, erlotinib may cause skin reactions such as rash, dryness, and itching, which are manifestations related to the drug's mechanism of action. Overseas guidelines recommend that patients moisturize before starting treatment, avoid sun exposure, and use mild skin care products. When an obvious rash occurs, you should seek medical treatment promptly to avoid affecting continued treatment.

The third taboo is to avoid smoking. Smoking increases CYP1A2 enzyme activity and accelerates the metabolism of erlotinib, resulting in a significant decrease in drug concentration. A large amount of overseas research data shows that failure to quit smoking will directly affect the efficacy of erlotinib, so doctors usually recommend that patients stop smoking completely during treatment.

In addition, grapefruit products should be avoided while taking the drug because the ingredients may interfere with drug metabolism and cause drug concentration to fluctuate. It is recommended to keep a light diet to reduce gastrointestinal discomfort, and to take medication on an empty stomach at the same time every day to maintain stable blood medication levels.

Reference materials:https://en.wikipedia.org/wiki/Erlotinib